Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Enero 2024 - 7:30AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that the company will
present at the 42nd Annual J.P. Morgan Healthcare Conference taking
place in San Francisco, CA from January 8-11, 2024.
Company Presentation Details:
Date: |
Monday,
January 8, 2024 |
|
|
Time: |
9-9:40 AM Pacific Time (12-12:40 PM Eastern Time) |
|
|
Presenter: |
Ian Mortimer, President and Chief Executive Officer, Xenon
Pharmaceuticals |
|
|
A live audio webcast of the company presentation will be
available on the “Investors” section of Xenon's website and posted
for replay following the event. The above listed dates and times
are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need.
For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: (604) 484-3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Gráfica de Acción Histórica
De May 2023 a May 2024